These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21453832)

  • 1. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials.
    Waters DD; Ho JE; DeMicco DA; Breazna A; Arsenault BJ; Wun CC; Kastelein JJ; Colhoun H; Barter P
    J Am Coll Cardiol; 2011 Apr; 57(14):1535-45. PubMed ID: 21453832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
    Wanner C; Krane V; März W; Olschewski M; Mann JF; Ruf G; Ritz E;
    N Engl J Med; 2005 Jul; 353(3):238-48. PubMed ID: 16034009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in cardiovascular events with atorvastatin in type 2 diabetes.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):9-10. PubMed ID: 16455007
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins on trial. Pfizer faces clot of lawsuits that claim Lipitor caused women's diabetes.
    Carlson J
    Mod Healthc; 2014 May; 44(20):20-2. PubMed ID: 25055462
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia.
    Lam HC; Chu CH; Wei MC; Keng HM; Lu CC; Sun CC; Lee JK; Chuang MJ; Wang MC; Tai MH
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1010-5. PubMed ID: 16741040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin and male infertility: is there a link?
    Niederberger C
    J Androl; 2005; 26(1):12. PubMed ID: 15611560
    [No Abstract]   [Full Text] [Related]  

  • 7. Atorvastatin-induced hemorrhagic cystitis: a case report.
    Martinez-Suarez HJ; Wang R; Faerber GJ
    Urology; 2009 Mar; 73(3):681.e5-6. PubMed ID: 18468659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.
    Hunninghake D; Bakker-Arkema RG; Wigand JP; Drehobl M; Schrott H; Early JL; Abdallah P; McBride S; Black DM
    J Fam Pract; 1998 Nov; 47(5):349-56. PubMed ID: 9834769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin: safety and tolerability.
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Expert Opin Drug Saf; 2010 Jul; 9(4):667-74. PubMed ID: 20553090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin induced multiple organ failure.
    Kandavar R; Sander GE
    J La State Med Soc; 2010; 162(3):159-60. PubMed ID: 20666169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus.
    Su Y; Xu Y; Sun YM; Li J; Liu XM; Li YB; Liu GD; Bi S
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):21-5. PubMed ID: 19786892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.
    Ramachandran S; Saraf S; Shetty C; Capps N; Bailey C
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):75-8. PubMed ID: 21115572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study.
    Ducobu J; Claeys M; Commers K; Van Mieghem W; Nachtergaele H; Vandenbroucke M; Deforce J
    Curr Med Res Opin; 2007 Aug; 23(8):1821-7. PubMed ID: 17609019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on type 2 diabetic dyslipidemia.
    Save V; Patil N; Moulik N; Rajadhyaksha G
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):262-70. PubMed ID: 17220473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin for stroke prevention.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
    [No Abstract]   [Full Text] [Related]  

  • 20. Usefulness of lymphocyte activation test in atorvastatin hypersensitivity.
    Piñero Saavedra MC; Prados Castaño M; Sánchez B; Lucena Soto JM; Avila Castellanos R; Ortega-Camarero M
    J Investig Allergol Clin Immunol; 2011; 21(7):574-5. PubMed ID: 22312946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.